US-based Elite Pharmaceuticals has announced that it is currently using and shipping packaged product from its 15,000ft² expanded facility.
Elite Pharmaceuticals chairman & CEO Jerry Treppel said shipping packaged product and manufacturing larger batch sizes from its new manufacturing space was one of its publicly announced operational goals for fiscal year 2013.
"It means we are now a fully integrated FDA and DEA approved facility capable of manufacturing for ourselves as well as others," Treppel said.
The company’s 15,000 ft² facility expansion includes cGMP manufacturing suites and packaging line.
According to the company, its packaging onsite provides cost reduction and the use of the new manufacturing suites allows for additional capacity and larger scale production.
Elite Pharmaceuticals develops oral sustained and controlled release products.